Barry Stein had ignored symptoms that started appearing in 1995, until he was diagnosed with stage four colorectal cancer.

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients ...

The rising rate of colon cancer in young people can't be caused by diet alone, doctors say. Microplastics, sleep, and antibiotics may play a role.

Researchers from the Cancer Epidemiology Unit at the University of Oxford, along with collaborators from international ...

Background: To fully assess predictive genetic testing programs ... distress in carriers of hereditary nonpolyposis colorectal cancer mutations. The past decade has seen predictive genetic ...

When gut bacteria breaks down plant fiber, they produce two compounds that act on genes to help prevent the growth of cancers ...

Amgen’s LUMAKRAS and Vectibix combination has received approval from the US FDA for treating KRAS G12C-mutated mCRC.

Dec. 23, 2024 — A research team has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them ...